Medisafe achieves main milestone with applicable registrations, anticipating the dynamic wants of the healthcare trade
BOSTON, Jan. 4, 2023 /PRNewswire/ — Medisafe, a number one digital therapeutics firm specializing in treatment engagement, is happy to announce its Software program as a Medical System (SaMD) know-how. This announcement comes simply months after attaining ISO 13485:2016 certification, assembly high quality administration system parameters particular to medical gadgets, in addition to ISO 27001:2013 certification, assembly IT safety administration system requirements particular to treatment and digital well being platforms. Worldwide registrations mark Medisafe’s continued management within the scientific administration and affected person engagement area.
Because the variety of software program for the administration of illness continues to develop, Medisafe’s development represents each the corporate’s dedication to adhering to regulatory requirements and exceeding trade expectations, in addition to its management within the progress of SaMD.
“We’re extremely pleased with our accomplishments over the previous yr to raised serve sufferers, clinicians, in addition to pharma companions,” stated Omri Shor, co-founder and CEO of Medisafe. “This most up-to-date announcement of registering as a SaMD is just not solely a vital step in our firm’s progress, it’s also crucial as leaders and innovators in digital therapeutics that we anticipate and resolve for evolving buyer and trade, regulated and non-regulated, wants.”
Along with these milestones, Medisafe can be persevering with to deal with the non-regulated facet of its enterprise constructing options that exceed the dynamic wants of pharma, HUBs, suppliers, and sufferers—together with the latest addition of its Salesforce CRM integration and Digital Doc Alternate in 2022. Medisafe’s end-to-end Care Connector platform helps pharma’s imaginative and prescient for a extra digitally-enhanced future by an interoperable, customized, and patient-centric method to digital affected person connectivity that enables organizations to effectively interact with sufferers all through their treatment journey. The worth that Medisafe’s platform and digital drug companion carry to sufferers is validated by the greater than 10 million registrants who use and depend on the know-how to handle their drugs.
Medisafe will probably be on website for the forty first Annual J.P. Morgan Healthcare Convention in San Francisco. To be taught extra about Medisafe’s latest developments and the way we’re supporting thousands and thousands of sufferers handle their drugs, keep engaged of their remedy, and create a digital assist system towards dwelling more healthy lives, go to www.medisafe.com.
Medisafe is the main treatment engagement platform that empowers sufferers to seamlessly handle their remedy journey. By combining superior know-how and habits science, Medisafe reimagines the remedy journey to information sufferers’ particular journey wants and drive day by day engagement. Its machine studying know-how fuels the holistic affected person engagement platform to personalize their assist wants in a scalable trend. By integrating present affected person assist packages into its platform to increase capabilities, Medisafe is constructing a seamless future mannequin of affected person assist and higher well being. Over 10M registered sufferers and caregivers depend on Medisafe’s platform, delivering double digit outcomes towards enhancing outcomes. The corporate manages over two billion treatment doses by way of iOS and Android smartphones and tablets. With a median ranking of 4.7 out of 5 stars and greater than 400,000 consumer evaluations, Medisafe helps to create extra day by day engagement than Fb or Twitter functions. Medisafe is a HIPAA and GDPR compliant answer and Medisafe is ISO 27001:2013 and ISO 13485:2016 licensed.